Targeting TBK1 Inhibits Migration and Resistance to MEK Inhibitors in Mutant NRAS Melanoma.

Vu HL, Aplin AE. Targeting TBK1 Inhibits Migration and Resistance to MEK Inhibitors in Mutant NRAS Melanoma. Mol Cancer Res. 2014 Oct; 12(10):1509-19.

View in: PubMed